• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies.

作者信息

Mufti G J, Figes A, Hamblin T J, Oscier D G, Copplestone J A

出版信息

Br J Haematol. 1986 May;63(1):143-7. doi: 10.1111/j.1365-2141.1986.tb07504.x.

DOI:10.1111/j.1365-2141.1986.tb07504.x
PMID:3707859
Abstract

The immunoglobulin levels and autoantibody profiles of 104 patients with primary myelodysplastic syndromes (MDS), classified according to the FAB criteria, were analysed. Eight patients, four with coexistent non-Hodgkin's lymphomas, three with chronic lymphocytic leukaemia and one with a lymphoplasmacytoma, were excluded from the final analysis of immunoglobulin levels. Serum protein electrophoresis and immunoelectrophoresis revealed the presence of monoclonal gammopathy in 12 patients (12.5%). Of the remaining 84 patients, a polyclonal rise in serum immunoglobulins was present in 27 (32%) while a further 16 (19%) had low immunoglobulin levels. The direct antiglobulin test was positive in eight out of 98 patients tested (8.1%), and organ and non-organ specific autoantibodies were present in 15 out of 67 patients tested (22.3%). Two patients had associated pernicious anaemia (PA), two hypothyroidism, and one PA with hypothyroidism. Three patients had sero-negative rheumatoid arthritis. These results demonstrate that there is a high incidence of immunological abnormalities in MDS.

摘要

相似文献

1
Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies.
Br J Haematol. 1986 May;63(1):143-7. doi: 10.1111/j.1365-2141.1986.tb07504.x.
2
Immune abnormalities in myelodysplastic syndromes.骨髓增生异常综合征中的免疫异常。
J Clin Pathol. 1985 Aug;38(8):908-11. doi: 10.1136/jcp.38.8.908.
3
Immunohematological findings in myelodysplastic syndrome.
Acta Haematol. 2001;105(1):1-6. doi: 10.1159/000046525.
4
[Immunological abnormalities in myelodysplastic syndromes--three cases with positive direct Coombs' test].骨髓增生异常综合征的免疫异常——3例直接抗人球蛋白试验阳性病例
Rinsho Ketsueki. 1987 May;28(5):713-20.
5
Erythrocyte autoantibodies, autoimmune haemolysis, and myelodysplastic syndromes.红细胞自身抗体、自身免疫性溶血和骨髓增生异常综合征。
J Clin Pathol. 1989 Oct;42(10):1088-91. doi: 10.1136/jcp.42.10.1088.
6
Monoclonal immunoglobulins and autoantibodies in lymphoid malignancies.淋巴系统恶性肿瘤中的单克隆免疫球蛋白和自身抗体。
Anticancer Res. 1990 Nov-Dec;10(6):1719-24.
7
Macroglobulinemia with positive antiglobulin tests.
Transfusion. 1970 Nov-Dec;10(6):310-4. doi: 10.1111/j.1537-2995.1970.tb00749.x.
8
Relationship between autoantibody and dermatosis in myelodysplastic syndrome.
Haematologia (Budap). 1993;25(4):253-61.
9
[Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].[112例骨髓增生异常综合征患者的免疫血液学研究:10年分析]
Sangre (Barc). 1995 Jun;40(3):177-80.
10
[Autoimmune hemolytic anemia and myelodysplastic syndromes].[自身免疫性溶血性贫血和骨髓增生异常综合征]
Sangre (Barc). 1989 Oct;34(5):343-5.

引用本文的文献

1
Hematologic malignancies masquerading as rheumatologic diseases: A case series and review.伪装成风湿性疾病的血液系统恶性肿瘤:病例系列报道及文献复习
Medicine (Baltimore). 2025 Apr 25;104(17):e42251. doi: 10.1097/MD.0000000000042251.
2
Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.甲氨蝶呤治疗自身免疫性风湿性疾病后出现的髓系肿瘤不具有不良风险分子特征。
Blood Cancer J. 2024 Jul 19;14(1):116. doi: 10.1038/s41408-024-01093-9.
3
Decitabine-containing conditioning improved outcomes for children with higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation.
地西他滨联合预处理方案改善高危骨髓增生异常综合征患儿异基因造血干细胞移植疗效
Ann Hematol. 2024 Apr;103(4):1345-1351. doi: 10.1007/s00277-024-05628-9. Epub 2024 Feb 6.
4
The successful treatment of microscopic polyangiitis associated with non-tuberculous mycobacterial-pulmonary disease.非结核分枝杆菌肺病相关显微镜下多血管炎的成功治疗
CEN Case Rep. 2024 Aug;13(4):271-276. doi: 10.1007/s13730-023-00839-x. Epub 2023 Dec 9.
5
What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias?体细胞突变在与骨髓增生异常肿瘤和慢性粒单核细胞白血病相关的全身炎症和自身免疫性疾病中起什么作用?
Leukemia. 2023 Jun;37(6):1186-1190. doi: 10.1038/s41375-023-01890-4. Epub 2023 Apr 6.
6
Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience.再探低危骨髓增生异常综合征:单中心经验中作为预后预测指标的形态学、自身免疫及分子特征
Front Oncol. 2022 Mar 22;12:795955. doi: 10.3389/fonc.2022.795955. eCollection 2022.
7
Immune Therapies for Myelodysplastic Syndromes and Acute Myeloid Leukemia.骨髓增生异常综合征和急性髓系白血病的免疫疗法
Cancers (Basel). 2021 Oct 8;13(19):5026. doi: 10.3390/cancers13195026.
8
Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?低增生性骨髓增生异常综合征:只是一种重叠综合征吗?
Cancers (Basel). 2021 Jan 3;13(1):132. doi: 10.3390/cancers13010132.
9
Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.靶向 FcRn 进行免疫调节:获益、风险和实际考虑。
J Allergy Clin Immunol. 2020 Sep;146(3):479-491.e5. doi: 10.1016/j.jaci.2020.07.016.
10
Successful Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Neuro-Sweet Disease in Myelodysplastic Syndrome.成功治疗骨髓增生异常综合征中与神经-斯韦特病相关的抗利尿激素分泌不当综合征
Intern Med. 2018 Feb 15;57(4):595-600. doi: 10.2169/internalmedicine.9215-17. Epub 2017 Dec 8.